Silverarc Capital Management’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-156,195
| Closed | -$175K | – | 77 |
|
|
2022
Q2 | $175K | Sell |
156,195
-79,320
| -34% | -$88.9K | 0.05% | 55 |
|
|
2022
Q1 | $264 | Buy |
235,515
+2,332
| +1% | +$3 | 0.11% | 56 |
|
|
2021
Q4 | $373K | Sell |
233,183
-132,478
| -36% | -$212K | 0.15% | 65 |
|
|
2021
Q3 | $885K | Sell |
365,661
-40,210
| -10% | -$97.3K | 0.5% | 57 |
|
|
2021
Q2 | $1.29K | Buy |
405,871
+230,871
| +132% | +$732 | 0.57% | 58 |
|
|
2021
Q1 | $590K | Sell |
175,000
-105,000
| -38% | -$354K | 0.32% | 65 |
|
|
2020
Q4 | $1M | Buy |
+280,000
| New | +$1M | 0.58% | 49 |
|